Yan Zou
Chongqing, 400016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy.
Journal: Therapeutic drug monitoring
Published: September 27, 2023
Smad Anchor for Receptor Activation and Phospho-Smad3 Were Upregulated in Patients with Temporal Lobe Epilepsy.
Journal: Journal of molecular neuroscience : MN
Published: December 05, 2018
Smad anchor for receptor activation contributes to seizures in temporal lobe epilepsy.
Journal: Synapse (New York, N.Y.)
Published: June 27, 2016
Time-Dependent Increase of Chitinase1 in APP/PS1 Double Transgenic Mice.
Journal: Neurochemical research
Published: August 29, 2015
Mitochondrial Sirt3 Expression is Decreased in APP/PS1 Double Transgenic Mouse Model of Alzheimer's Disease.
Journal: Neurochemical research
Published: December 20, 2014
Altered cerebrospinal fluid concentrations of TGFβ1 in patients with drug-resistant epilepsy.
Journal: Neurochemical research
Published: February 04, 2014
Vascular risk factors and mild cognitive impairment in the elderly population in Southwest China.
Journal: American journal of Alzheimer's disease and other dementias
Published: December 31, 2013
Synchronous alteration pattern between serine-threonine kinase receptor-associated protein and Smad7 in pilocarpine-induced rats of epilepsy.
Journal: Synapse (New York, N.Y.)
Published: September 29, 2013
Hypoxia-up-regulated mitochondrial movement regulator does not contribute to the APP/PS1 double transgenic mouse model of Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders
Published: April 05, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026